scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH · IEX Real-Time Price · USD
5.02
-0.01 (-0.20%)
At close: Mar 28, 2024, 4:00 PM
5.11
+0.09 (1.79%)
After-hours: Mar 28, 2024, 4:05 PM EDT

scPharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Cash & Equivalents
46.8171.2474.457272.8189.66118.4839.281.57
Short-Term Investments
29.247.131.0133.2800000
Cash & Cash Equivalents
76.01118.3775.46105.2872.8189.66118.4839.281.57
Cash Growth
-35.78%56.86%-28.32%44.60%-18.80%-24.32%201.61%2397.27%-
Receivables
4.4900000000
Inventory
8.841.230000000
Other Current Assets
3.63.712.822.552.842.231.40.460.25
Total Current Assets
92.94123.3178.28107.8375.6591.89119.8839.741.82
Property, Plant & Equipment
1.460.620.480.911.311.671.980.030.02
Other Long-Term Assets
0.080.270.280.310.330.190.190.010.01
Total Long-Term Assets
1.540.890.761.221.641.862.170.030.03
Total Assets
94.48124.279.04109.0577.2893.76122.0539.771.85
Accounts Payable
41.520.541.671.140.591.591.550.68
Current Debt
0.180.5710.282.870.413.160.5600
Other Current Liabilities
8.965.334.024.793.692.923.062.191.32
Total Current Liabilities
13.137.4214.859.325.246.675.213.742.01
Long-Term Debt
40.0936.87.3517.3419.868.1810.7900
Other Long-Term Liabilities
4.037.550.370.220.820.160.050.010.01
Total Long-Term Liabilities
44.1344.357.7217.5620.688.3410.840.010.01
Total Liabilities
57.2651.7622.5726.8825.9215.0116.053.742.01
Total Debt
40.2737.3717.6420.2120.2711.3411.3400
Debt Growth
7.76%111.90%-12.72%-0.29%78.66%-0.01%---
Retained Earnings
-281.35-226.54-189.7-161.66-129.46-96.46-67.02-43.2-18.82
Comprehensive Income
-00.03-0000000
Shareholders' Equity
37.2272.4356.4782.1751.3778.74106-37.07-18.24
Net Cash / Debt
35.748157.8385.0752.5478.32107.1439.281.57
Net Cash / Debt Growth
-55.87%40.08%-32.03%61.91%-32.91%-26.90%172.74%2397.27%-
Net Cash Per Share
0.932.862.113.462.824.2236.1640.302.06
Working Capital
79.8115.8963.4398.5170.4185.22114.6736-0.19
Book Value Per Share
0.972.552.063.342.764.2435.77-38.04-23.90
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).